197 related articles for article (PubMed ID: 8261806)
61. Toxicity and side effects of hydroxyurea used for primary thrombocythemia.
Randi ML; Ruzzon E; Tezza F; Luzzatto G; Fabris F
Platelets; 2005; 16(3-4):181-4. PubMed ID: 16011962
[TBL] [Abstract][Full Text] [Related]
62. The effect of hydroxyurea on hemoglobin F in patients with myeloproliferative syndromes.
Alter BP; Gilbert HS
Blood; 1985 Aug; 66(2):373-9. PubMed ID: 2410068
[TBL] [Abstract][Full Text] [Related]
63. Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
Kiladjian JJ; Rain JD; Bernard JF; Briere J; Chomienne C; Fenaux P
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):417-21. PubMed ID: 16810617
[TBL] [Abstract][Full Text] [Related]
64. [Appearance of leg ulcers associated with intake of anagrelide].
Rappoport L; Körber A; Grabbe S; Dissemond J
Dtsch Med Wochenschr; 2007 Feb; 132(7):319-21. PubMed ID: 17286219
[TBL] [Abstract][Full Text] [Related]
65. Hydroxyurea-induced ulcers on the leg.
Dissemond J; Körber A
CMAJ; 2009 May; 180(11):1132. PubMed ID: 19468123
[No Abstract] [Full Text] [Related]
66. Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy.
Ruella M; Salmoiraghi S; Risso A; Carobbio A; Buttiglieri S; Spatola T; Sivera P; Ricca I; Barbui T; Tarella C; Rambaldi A
Exp Hematol; 2013 Jul; 41(7):627-34. PubMed ID: 23542632
[TBL] [Abstract][Full Text] [Related]
67. Cutaneous involvement by post-polycythemia vera myelofibrosis.
Pecci A; Croci G; Balduini CL; Boveri E
Am J Hematol; 2014 Apr; 89(4):448. PubMed ID: 23877876
[No Abstract] [Full Text] [Related]
68. [Multiple, painful, treatment-resistant leg ulcers associated with dermatomyositis-like lesions over the interphalangeal joints induced by hydroxyurea].
Martorell-Calatayud A; Requena C; Nagore-Enguídanos E; Guillén-Barona C
Actas Dermosifiliogr; 2009 Nov; 100(9):804-7. PubMed ID: 19889302
[TBL] [Abstract][Full Text] [Related]
69. Cutaneous effects after prolongaded use of hydroxyurea in Polycythemia Vera.
França ER; Teixeira MA; Matias Kde F; Antunes DE; Braz Rde A; Silva CE
An Bras Dermatol; 2011; 86(4):751-4. PubMed ID: 21987143
[TBL] [Abstract][Full Text] [Related]
70. A case of lower limb ulcer caused by hydroxyurea in treating primary thrombocytosis.
Shi Y; Wu Z
Trop Doct; 2024 Apr; 54(2):200-201. PubMed ID: 38087420
[TBL] [Abstract][Full Text] [Related]
71. Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis.
Demuynck T; Verhoef G; Delforge M; Vandenberghe P; Devos T
Ann Hematol; 2019 Jun; 98(6):1421-1426. PubMed ID: 30919072
[TBL] [Abstract][Full Text] [Related]
72. Leg ulceration with associated thrombocytosis: healing of ulceration associated with treatment of the raised platelet count.
Varma S; Lanigan SW
Br J Dermatol; 1999 Jan; 140(1):188-9. PubMed ID: 10215806
[No Abstract] [Full Text] [Related]
73. Multiple skin cancers associated with hydroxyurea therapy.
Best PJ; Petitt RM
Mayo Clin Proc; 1998 Oct; 73(10):961-3. PubMed ID: 9787746
[TBL] [Abstract][Full Text] [Related]
74. Chronic Myeloid Leukaemia with Sudden Bilateral Deafness and Leg Ulcer Associated with Hydroxyurea Therapy.
Ugwu NI; Okoye AE; Ugwu CN; Ibiam FA; Nnachi OA; Ugwu GC; Okoh NU
West Afr J Med; 2021 May; 38(5):502-506. PubMed ID: 34051725
[TBL] [Abstract][Full Text] [Related]
75. Malleolar ulcers due to hidroxyurea treatment.
Bueno-Rodríguez A; Aguayo-Carreras P; Martínez-López A; Pérez-López I; Ruiz-Villaverde R
Med Clin (Barc); 2017 Aug; 149(4):e23. PubMed ID: 27986269
[No Abstract] [Full Text] [Related]
76. Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: successful treatment with prostagladin E1 and pentoxifylline.
Kido M; Tago O; Fujiwara H; Ito M; Niwano H
Br J Dermatol; 1998 Dec; 139(6):1124-6. PubMed ID: 9990395
[No Abstract] [Full Text] [Related]
77. Leg ulceration with associated thrombocytosis: healing of ulceration associated with treatment of the raised platelet count.
Wirth K; Schoepf E; Mertelsmann R; Lindemann A
Br J Dermatol; 1998 Mar; 138(3):533-5. PubMed ID: 9580816
[TBL] [Abstract][Full Text] [Related]
78. Hydroxyurea dermopathy with a dermatomyositis-like eruption and a large leg ulcer.
Suehiro M; Kishimoto S; Wakabayashi T; Ikeuchi A; Miyake H; Takenaka H; Okano A; Hirai H; Shimazaki C; Yasuno H
Br J Dermatol; 1998 Oct; 139(4):748-9. PubMed ID: 9892930
[No Abstract] [Full Text] [Related]
79. Cutaneous ulcers associated with hydroxyurea therapy in myeloproliferative disorders.
Ravandi-Kashani F; Cortes J; Cohen P; Talpaz M; O'Brien S; Markowitz A; Kantarjian H
Leuk Lymphoma; 1999 Sep; 35(1-2):109-18. PubMed ID: 10512168
[TBL] [Abstract][Full Text] [Related]
80. Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis.
Ferrari A; Carobbio A; Masciulli A; Ghirardi A; Finazzi G; De Stefano V; Vannucchi AM; Barbui T
Haematologica; 2019 Dec; 104(12):2391-2399. PubMed ID: 31123026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
